Science Applications International Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Science Applications International Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	4,442	4,454	4,659	6,379	7,056	7,394	7,704	7,444	7,479	7,262
Cost of revenue	4,003	4,043	4,195	5,673	6,264	6,535	6,816	6,572	6,587	6,390
Gross profit	439	411	464	706	792	859	888	872	892	872
Research and development	4	4	5	7	6	4	1	4	12	13
Selling, general and administrative	166	155	158	288	352	344	374	373	339	350
Operating income	263	256	220	370	390	462	501	741	563	521
Interest expense	52	44	53	90	122	105	120
Other non-operating income	1	2	3	6	3	1	-8	-1	-9	-6
Pre-tax income	212	214	170	286	271	358	375	620	428	387
Income tax	69	35	33	57	60	79	72	143	66	29
Net income to minority interests	0	0	0	3	2	2	3	0	0
Net income	143	179	137	226	209	277	300	477	362	358
EBITDA	286	279	243	406	422	499	533	767	588	551
EPS, basic	3.21	4.13	3.16	3.87	3.60	4.81	5.42	8.98	7.23	7.73
EPS, diluted	3.12	4.02	3.11	3.83	3.56	4.77	5.38	8.88	7.17	7.70
Shares, basic (weighted)	44.5	43.3	43.4	58.4	58.1	57.6	55.3	53.1	50.1	46.3
Shares, diluted (weighted)	45.9	44.5	44.1	59	58.7	58.1	55.8	53.7	50.5	46.5
Dividend per share	1.24	1.24	0.31	0.37	0.37	0.37	0.37	0.37	0.37	0.37

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	210	144	237	188	171	106	109	94	56	182
Receivables	539	674	1,050	1,099	962	1,015	936	914	1,000	853
Inventory	71	68	74	84	78	64	71	3
Other current assets	54	29	25	19	22	21	23	30	20	22
Total current assets	901	950	1,433	1,430	1,289	1,263	1,197	1,131	1,154	1,179
Property, plant and equipment	60	61	103	91	108	100	92	91	104	110
Lease right-of-use assets			0	190	236	209	158	152	164	193
Goodwill	863	863	2,120	2,139	2,787	2,913	2,911	2,851	2,851	2,944
Intangible assets	200	179	803	711	1,138	1,132	1,009	894	779	761
Long-term investments			4	27	27	28	28	32	36
Other non-current assets	18	20	104	150	165	129	162	195	194	167
Total assets	2,042	2,073	4,563	4,711	5,723	5,746	5,543	5,314	5,246	5,354
Accounts payable	329	397	455	527	517	612	624	567	631	500
Accrued liabilities	158	150	241	244	346	364	328	370	339	316
Deferred revenue									38	41
Short-term debt	25	41	24	70	68	148	31	77	313	19
Total current liabilities	623	695	897	1,128	1,275	1,352	1,126	1,158	1,396	982
Long-term debt	1,022	983	2,065	1,851	2,447	2,370	2,343	2,022	1,907	2,468
Lease liabilities			0	172	205	192	152	147	173	198
Other non-current liabilities	38	45	102	133	242	160	218	174	169	102
Total liabilities	1,693	1,746	3,064	3,284	4,171	4,117	3,839	3,529	3,669	3,854
Total debt	1,047	1,024	2,089	1,921	2,515	2,518	2,374	2,099	2,220	2,487
Paid-in capital	91	0	1,132	983	1,004	838	637	337	0	0
Retained earnings	260	323	367	506	627	818	1,035	1,432	1,565	1,492
Other comprehensive income	-2	4	-14	-72	-89	-37	22	16	12	8
Shareholders' equity	349	327	1,485	1,417	1,542	1,619	1,694	1,785	1,577	1,500
Minority interests		0	14	10	10	10	10	0
Total equity	349	327	1,499	1,427	1,552	1,629	1,704	1,785	1,577	1,500
Total liabilities and equity	2,042	2,073	4,563	4,711	5,723	5,746	5,543	5,314	5,246	5,354
Shares outstanding	44	43	60	58	58	56	54	52	48	44

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	143	179	137	229	211	279	303	477	362	358
Depreciation and amortization	23	23	23	36	32	37	32	26	25	30
Stock-based compensation	31	27	45	37	42	46	48	68	53	64
Deferred income tax	-2	13	19	44	12	59	-17	-17	-3	81
Change in receivables	96	-135	-26	-50	221	-31	79	-46	-86	161
Change in payables	24	68	-65	62	-76	30	-9	13	48	-101
Cash from operations	273	217	184	458	755	518	532	396	494	609
Capital expenditures	-15	-22	-28	-21	-46	-36	-25	-27	-36	-32
Acquisitions	0	0	-1,001	0	-1,202	-255	0	0	0	-203
Purchases of investments		0	0	-24	-6	-9	-7	-8	-14	-9
Sales and maturities of investments		0	0	3	9	6	4	6	12	7
Cash from investing	-17	-22	-1,028	-47	-1,231	-292	-36	314	-35	-248
Debt issued	209	25	1,859	100	1,000	116	840	160	1,499	2,745
Debt repaid	-236	-50	-779	-274	-399	-119	-990	-441	-1,381	-2,474
Stock issued	5	6	7	10	13	16	16	17	20	22
Share buybacks	-180	-186	-69	-197	-34	-226	-267	-382	-558	-445
Dividends paid	-54	-54	-53	-87	-87	-86	-83	-79	-75	-70
Cash from financing	-247	-261	938	-455	464	-301	-493	-725	-498	-235
Net change in cash	9	-66	94	-44	-12	-75	3	-15	-39	126
Free cash flow	258	195	156	437	709	482	507	369	458	577
Interest paid	48	41	44	86	96	98	111	125	121	101
Income taxes paid	46	31	24	32	39	7	70	165	66	22

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $132.61 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	12.6%	Gross profit / revenue.
Operating margin	8.0%	Operating income / revenue.
EBITDA margin	9.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	6.2%	Pre-tax income / revenue.
Net margin	5.1%	Net income / revenue.
FCF margin	8.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.9%	Cash from operations / revenue.
Effective tax rate	16.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	26.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.0%	Net income / average total assets.
Return on invested capital (ROIC)	13.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	4.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.6%	Capital expenditures / revenue.
D&A / revenue	1.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-2.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-7.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	1.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-6.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	1.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	5.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-1.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	6.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	11.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	7.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	12.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	16.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	23.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-4.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	26.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	4.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-4.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-4.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-4.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-0.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-7.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-5.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-4.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.20x	Current assets / current liabilities.
Quick ratio	1.06x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.12x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.73x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	45.8%	Total debt / total assets.
Liabilities / assets	73.5%	Total liabilities / total assets.
Net debt	$2.36B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.43x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$217.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	67.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.20B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.36x	Revenue / average total assets.
Fixed asset turnover	60.7x	Revenue / average property, plant and equipment.
Receivables turnover	7.43x	Revenue / average receivables.
Days sales outstanding	49 days	365 x average receivables / revenue.
FCF conversion	162.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	6.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$8.88	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$172.94	Revenue / diluted weighted shares.
FCF per share	$14.46	Free cash flow / diluted weighted shares.
Operating cash flow per share	$15.42	Cash from operations / diluted weighted shares.
Book value per share	$34.19	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$52.48	Tangible book value / shares outstanding.
Cash per share	$3.00	(Cash + short-term investments) / shares outstanding.
Payout ratio	17.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	10.8%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	77.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.61B	Share price x shares outstanding.
Enterprise value	$7.97B	Market cap + total debt - cash - short-term investments.
P/E	14.8x	Market cap / net income. Only when net income is positive.
P/S	0.76x	Market cap / revenue.
P/B	3.90x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	9.06x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.49x	Market cap / cash from operations, when positive.
EV/Sales	1.08x	Enterprise value / revenue.
EV/EBIT	13.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	12.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	11.0%	Free cash flow / market cap.
Earnings yield	6.8%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	9.7%	(Dividends paid + share buybacks) / market cap.
PEG	1.16x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Science Applications International Corp's revenue in fiscal 2026?

Science Applications International Corp reported revenue of $7.26B for fiscal 2026, 2.9% lower than the year before.

Was Science Applications International Corp profitable in fiscal 2026?

Yes. Net income was $358.0M, a net margin of 4.9%.

How much free cash flow did Science Applications International Corp generate in fiscal 2026?

Cash from operations of $609.0M minus capital expenditures of $32.0M left free cash flow of $577.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Science Applications International Corp